Latest Insider Transactions at Tela Bio, Inc. (TELA)
This section provides a real-time view of insider transactions for Tela Bio, Inc. (TELA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TELA Bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TELA Bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 11
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.15%
|
$40,000
$8.82 P/Share
|
|
May 10
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.15%
|
$45,000
$9.27 P/Share
|
|
May 09
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.15%
|
$45,000
$9.38 P/Share
|
|
May 06
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.15%
|
$45,000
$9.55 P/Share
|
|
May 05
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.15%
|
$45,000
$9.62 P/Share
|
|
May 04
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.15%
|
$45,000
$9.53 P/Share
|
|
May 03
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.15%
|
$45,000
$9.4 P/Share
|
|
May 02
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.15%
|
$45,000
$9.32 P/Share
|
|
Apr 29
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.15%
|
$45,000
$9.17 P/Share
|
|
Apr 28
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.15%
|
$45,000
$9.09 P/Share
|
|
Apr 27
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.15%
|
$45,000
$9.05 P/Share
|
|
Apr 26
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.3%
|
$90,000
$9.24 P/Share
|
|
Apr 25
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.15%
|
$45,000
$9.49 P/Share
|
|
Apr 19
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
3,200
+0.1%
|
$28,800
$9.84 P/Share
|
|
Apr 18
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.15%
|
$45,000
$9.8 P/Share
|
|
Apr 14
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
589
+0.02%
|
$5,890
$10.0 P/Share
|
|
Apr 01
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
684
+0.02%
|
$7,524
$11.45 P/Share
|
|
Mar 31
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.15%
|
$55,000
$11.54 P/Share
|
|
Mar 31
2022
|
Antony Koblish Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
384
-0.16%
|
$4,224
$11.63 P/Share
|
|
Mar 31
2022
|
Peter C. Murphy Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
163
-0.7%
|
$1,793
$11.63 P/Share
|
|
Mar 31
2022
|
Paul Talmo Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
185
-0.44%
|
$2,035
$11.63 P/Share
|
|
Mar 31
2022
|
Megan Smeykal Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
93
-0.76%
|
$1,023
$11.63 P/Share
|
|
Mar 30
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,645
+0.08%
|
$29,095
$11.65 P/Share
|
|
Mar 29
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
3,052
+0.09%
|
$33,572
$11.65 P/Share
|
|
Mar 22
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
136
+0.0%
|
$1,496
$11.65 P/Share
|
|
Mar 16
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,331
+0.07%
|
$25,641
$11.65 P/Share
|
|
Mar 15
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
100
+0.0%
|
$1,100
$11.65 P/Share
|
|
Mar 14
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
3,473
+0.11%
|
$38,203
$11.68 P/Share
|
|
Feb 24
2022
|
Antony Koblish Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,687
-1.12%
|
$29,557
$11.98 P/Share
|
|
Feb 24
2022
|
Ellis Skott Greenhalgh Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
973
-3.38%
|
$10,703
$11.98 P/Share
|
|
Feb 24
2022
|
Peter C. Murphy Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
939
-3.86%
|
$10,329
$11.98 P/Share
|
|
Feb 24
2022
|
Paul Talmo Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,023
-2.4%
|
$11,253
$11.98 P/Share
|
|
Feb 24
2022
|
Megan Smeykal Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
535
-4.21%
|
$5,885
$11.98 P/Share
|
|
Feb 24
2022
|
Antony Koblish Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,500
+16.18%
|
-
|
|
Feb 24
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,572
+0.17%
|
$61,292
$11.74 P/Share
|
|
Feb 23
2022
|
Peter C. Murphy Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,800
+30.77%
|
-
|
|
Feb 23
2022
|
Roberto Cuca COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,500
+43.8%
|
-
|
|
Feb 23
2022
|
Megan Smeykal Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+28.22%
|
-
|
|
Feb 23
2022
|
Paul Talmo Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,200
+22.23%
|
-
|
|
Feb 23
2022
|
Ellis Skott Greenhalgh Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,900
+11.93%
|
-
|
|
Feb 23
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
750,657
+18.56%
|
$8,257,227
$11.75 P/Share
|
|
Feb 22
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
3,579
+0.14%
|
$39,369
$11.74 P/Share
|
|
Feb 18
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,520
+0.1%
|
$27,720
$11.75 P/Share
|
|
Feb 17
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
6,810
+0.27%
|
$74,910
$11.73 P/Share
|
|
Feb 16
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.39%
|
$110,000
$11.72 P/Share
|
|
Feb 15
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
29
+0.0%
|
$319
$11.75 P/Share
|
|
Feb 14
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
10
+0.0%
|
$110
$11.75 P/Share
|
|
Feb 11
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
7,082
+0.28%
|
$77,902
$11.74 P/Share
|
|
Feb 10
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
520
+0.02%
|
$5,720
$11.75 P/Share
|
|
Feb 09
2022
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,327
+0.05%
|
$14,597
$11.75 P/Share
|